E
MindBio Therapeutics Corp. MBIO
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -247.20K -30.70K -168.70K 50.50K -26.10K
Total Depreciation and Amortization 57.80K -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 60.00K -67.70K 170.30K 46.60K -86.70K
Change in Net Operating Assets 38.00K 44.50K -17.90K -2.70K 27.40K
Cash from Operations -91.40K -53.90K -16.30K 94.30K -85.40K
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid 0.00 -8.00K -12.60K -- --
Issuance of Common Stock 165.00K -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 0.00 0.00 0.00
Cash from Financing 107.50K -5.40K -8.30K 0.00 0.00
Foreign Exchange rate Adjustments -- -- -45.60K -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 16.20K -59.20K -70.30K 94.30K -85.40K
Weiss Ratings